Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001432286 | SCV001635051 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-08-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001703096 | SCV002074070 | likely benign | not provided | 2021-08-05 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26582918) |
Ambry Genetics | RCV002368342 | SCV002664694 | likely benign | Cardiovascular phenotype | 2019-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001703096 | SCV004161047 | likely benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV001703096 | SCV001931461 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001703096 | SCV001958505 | likely benign | not provided | no assertion criteria provided | clinical testing |